5.1. Study Subjects
allergy, skin infection, neurological disease
NEUROLOGICAL DISEASE, ALLERGY, SKIN INFECTION, MALIGNANCIES, DISEASES
This study included female-to-male patients aged 18 years and above. Exclusion criteria encompassed the following: a known history of allergy to BoNT-A, BoNT-A injection within the past 6 months, a history of neurological disease or deficit, concurrent severe underlying or uncontrolled diseases such as malignancies or uncontrolled comorbidities, and the presence of skin infection in the treated area.